Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Leukemia Stem Cell-based Assay to Predict Relapse and Survival in Patients With Acute Myeloid Leukemia

NCT07537738 is registered in ClinicalTrials.gov with Peking University People's Hospital as lead sponsor.

NCT NCT07537738
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07537738 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Leukemia Stem Cell-based Assay to Predict Relapse and Survival in Patients With Acute Myeloid Leukemia
Lead sponsor
Peking University People's Hospital
Phase
Observational
Overall status
Recruiting
Start date
June 1, 2025
Completion date
April 7, 2026
Enrollment
210 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia (aml), mll rearrangement